Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis
NCT03652090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112
Last updated 2019-03-12
Summary
characterization of CFTR function and expression in nasal primary cells collected from patients with cystic fibrosis in comparison to their parents, healthy heterozygotes and healthy controls
Conditions
Interventions
- PROCEDURE
-
cell sampling
nasal brushing to collect cells
Sponsors & Collaborators
-
ABCF2
collaborator UNKNOWN -
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-01
- Primary Completion
- 2016-03-03
- Completion
- 2016-03-03
More Related Trials
-
High Flow Nasal Oxygen for Children With Cystic Fibrosis Presenting With Respiratory Failure - a Randomized Controlled Study
NCT01810536 ·Status: TERMINATED ·Phase: NA
-
Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
NCT04580368 ·Status: RECRUITING ·Phase: NA
-
Correction of Nonsense Mutations in Cystic Fibrosis
NCT03670472 ·Status: RECRUITING
-
Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome
NCT05982795 ·Status: RECRUITING
-
Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
NCT02564354 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Single Dose of pGM169/GL67A in CF Patients
NCT00789867 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Breath Analysis in in Adults With Cystic Fibrosis (CF)
NCT02209571 ·Status: COMPLETED ·Phase: NA
-
Cystic Fibrosis (CF) Flow Rates Study
NCT00779077 ·Status: COMPLETED
-
Real-world Efficacy and Safety of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy in Adult Patients With Cystic Fibrosis (CF)
NCT05526027 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis
NCT02003079 ·Status: COMPLETED
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394 ·Status: RECRUITING
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis
NCT05740618 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
NCT04396366 ·Status: TERMINATED ·Phase: PHASE2
-
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
NCT05392855 ·Status: TERMINATED ·Phase: NA
-
Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis
NCT05239611 ·Status: COMPLETED ·Phase: PHASE2
-
Muscle Function and Physical Activity in the Modern Era of Cystic Fibrosis
NCT06251622 ·Status: RECRUITING
-
Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
NCT06507956 ·Status: RECRUITING
-
Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function
NCT01685801 ·Status: COMPLETED ·Phase: PHASE2
-
Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
NCT00537602 ·Status: TERMINATED ·Phase: PHASE2
-
Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis
NCT05604495 ·Status: RECRUITING
-
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs
NCT04353752 ·Status: COMPLETED
-
Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings
NCT00685035 ·Status: COMPLETED ·Phase: PHASE4
-
Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants With Cystic Fibrosis
NCT01605565 ·Status: COMPLETED ·Phase: NA